Cargando…

Transcriptional Repression of Raf Kinase Inhibitory Protein Gene by Metadherin during Cancer Progression

Raf kinase inhibitory protein (RKIP), also known as a phosphatidylethanolamine-binding protein 1 (PEBP1), functions as a tumor suppressor and regulates several signaling pathways, including ERK and NF- [Formula: see text] B. RKIP is severely downregulated in human malignant cancers, indicating a fun...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Trang Huyen, Ahmed, Mahmoud, Hwang, Jin Seok, Zada, Sahib, Pham, Trang Minh, Elashkar, Omar, Kim, Deok Ryong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002422/
https://www.ncbi.nlm.nih.gov/pubmed/33802672
http://dx.doi.org/10.3390/ijms22063052
_version_ 1783671459927818240
author Lai, Trang Huyen
Ahmed, Mahmoud
Hwang, Jin Seok
Zada, Sahib
Pham, Trang Minh
Elashkar, Omar
Kim, Deok Ryong
author_facet Lai, Trang Huyen
Ahmed, Mahmoud
Hwang, Jin Seok
Zada, Sahib
Pham, Trang Minh
Elashkar, Omar
Kim, Deok Ryong
author_sort Lai, Trang Huyen
collection PubMed
description Raf kinase inhibitory protein (RKIP), also known as a phosphatidylethanolamine-binding protein 1 (PEBP1), functions as a tumor suppressor and regulates several signaling pathways, including ERK and NF- [Formula: see text] B. RKIP is severely downregulated in human malignant cancers, indicating a functional association with cancer metastasis and poor prognosis. The transcription regulation of RKIP gene in human cancers is not well understood. In this study, we suggested a possible transcription mechanism for the regulation of RKIP in human cancer cells. We found that Metadherin (MTDH) significantly repressed the transcriptional activity of RKIP gene. An analysis of publicly available datasets showed that the knockdown of MTDH in breast and endometrial cancer cell lines induced the expression RKIP. In addition, the results obtained from qRT-PCR and ChIP analyses showed that MTDH considerably inhibited RKIP expression. In addition, the RKIP transcript levels in MTDH-knockdown or MTDH-overexpressing MCF-7 cells were likely correlated to the protein levels, suggesting that MTDH regulates RKIP expression. In conclusion, we suggest that MTDH is a novel factor that controls the RKIP transcription, which is essential for cancer progression.
format Online
Article
Text
id pubmed-8002422
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80024222021-03-28 Transcriptional Repression of Raf Kinase Inhibitory Protein Gene by Metadherin during Cancer Progression Lai, Trang Huyen Ahmed, Mahmoud Hwang, Jin Seok Zada, Sahib Pham, Trang Minh Elashkar, Omar Kim, Deok Ryong Int J Mol Sci Article Raf kinase inhibitory protein (RKIP), also known as a phosphatidylethanolamine-binding protein 1 (PEBP1), functions as a tumor suppressor and regulates several signaling pathways, including ERK and NF- [Formula: see text] B. RKIP is severely downregulated in human malignant cancers, indicating a functional association with cancer metastasis and poor prognosis. The transcription regulation of RKIP gene in human cancers is not well understood. In this study, we suggested a possible transcription mechanism for the regulation of RKIP in human cancer cells. We found that Metadherin (MTDH) significantly repressed the transcriptional activity of RKIP gene. An analysis of publicly available datasets showed that the knockdown of MTDH in breast and endometrial cancer cell lines induced the expression RKIP. In addition, the results obtained from qRT-PCR and ChIP analyses showed that MTDH considerably inhibited RKIP expression. In addition, the RKIP transcript levels in MTDH-knockdown or MTDH-overexpressing MCF-7 cells were likely correlated to the protein levels, suggesting that MTDH regulates RKIP expression. In conclusion, we suggest that MTDH is a novel factor that controls the RKIP transcription, which is essential for cancer progression. MDPI 2021-03-17 /pmc/articles/PMC8002422/ /pubmed/33802672 http://dx.doi.org/10.3390/ijms22063052 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lai, Trang Huyen
Ahmed, Mahmoud
Hwang, Jin Seok
Zada, Sahib
Pham, Trang Minh
Elashkar, Omar
Kim, Deok Ryong
Transcriptional Repression of Raf Kinase Inhibitory Protein Gene by Metadherin during Cancer Progression
title Transcriptional Repression of Raf Kinase Inhibitory Protein Gene by Metadherin during Cancer Progression
title_full Transcriptional Repression of Raf Kinase Inhibitory Protein Gene by Metadherin during Cancer Progression
title_fullStr Transcriptional Repression of Raf Kinase Inhibitory Protein Gene by Metadherin during Cancer Progression
title_full_unstemmed Transcriptional Repression of Raf Kinase Inhibitory Protein Gene by Metadherin during Cancer Progression
title_short Transcriptional Repression of Raf Kinase Inhibitory Protein Gene by Metadherin during Cancer Progression
title_sort transcriptional repression of raf kinase inhibitory protein gene by metadherin during cancer progression
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002422/
https://www.ncbi.nlm.nih.gov/pubmed/33802672
http://dx.doi.org/10.3390/ijms22063052
work_keys_str_mv AT laitranghuyen transcriptionalrepressionofrafkinaseinhibitoryproteingenebymetadherinduringcancerprogression
AT ahmedmahmoud transcriptionalrepressionofrafkinaseinhibitoryproteingenebymetadherinduringcancerprogression
AT hwangjinseok transcriptionalrepressionofrafkinaseinhibitoryproteingenebymetadherinduringcancerprogression
AT zadasahib transcriptionalrepressionofrafkinaseinhibitoryproteingenebymetadherinduringcancerprogression
AT phamtrangminh transcriptionalrepressionofrafkinaseinhibitoryproteingenebymetadherinduringcancerprogression
AT elashkaromar transcriptionalrepressionofrafkinaseinhibitoryproteingenebymetadherinduringcancerprogression
AT kimdeokryong transcriptionalrepressionofrafkinaseinhibitoryproteingenebymetadherinduringcancerprogression